4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9403772
APP PUB NO 20150011510A1
SERIAL NO

14360991

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the neurokinin (NK1) receptor, based on 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)3yridine-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium and pharmaceutically acceptable salts thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HELSINN HEALTHCARE SA6912 LUGANO-PAZZALLO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cannella, Roberta Varese, IT 39 157
Fadini, Luca Giubiasco, CH 11 28
Giuliano, Claudio Como, IT 25 69
Lovati, Emanuela Mendrisio, CH 12 28
Manini, Peter Giubiasco, CH 27 431
Pietra, Claudio Como, IT 32 44
Stella, Valentino J Lawrence, US 52 2110
Venturini, Alessio Varese, IT 13 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 2, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00